Example: Heart Attack

Clinical Trials on Acute Promyelocytic Leukemia

Total 151 results

NCT03624270

Recruiting

Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia

Conditions: Acute Promyelocytic Leukemia
NCT03751917

Recruiting

Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT03096496

Active, not recruiting

Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy

Conditions: Acute Promyelocytic Leukemia
NCT02899169

Unknown status

Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)

Conditions: Acute Promyelocytic Leukemia
NCT04251754

Recruiting

The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project

Conditions: Acute Promyelocytic Leukemia
NCT02991066

Unknown status

Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT04793919

Recruiting

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT02688140

Recruiting

Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT00465933

Completed

Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)

Conditions: Acute Promyelocytic Leukemia
NCT00408278

Completed

Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)

Conditions: Acute Promyelocytic Leukemia
NCT01950611

Unknown status

Proteasome Inhibition in Acute Promyelocytic Leukemia

Conditions: Relapsed Acute Promyelocytic Leukemia
NCT02938858

Recruiting

French Registry of First-line Treatment of Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT01910623

Completed

Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT00517712

Unknown status

Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT00675870

Unknown status

Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT01404949

Completed

Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

Conditions: Acute Promyelocytic Leukemia
NCT00985530

Terminated

Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT00196768

Unknown status

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

Conditions: Relapsed Acute Promyelocytic Leukemia; Refractory Acute Promyelocytic Leukemia
NCT00670150

Withdrawn

New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia
NCT02339740

Active, not recruiting

Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia With PML-RARA
NCT01409161

Recruiting

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Conditions: Acute Promyelocytic Leukemia With PML-RARA
NCT00504764

Completed

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

Conditions: Acute Promyelocytic Leukemia
NCT04687176

Recruiting

Frontline Oral Arsenic Trioxide for APL

Conditions: Acute Promyelocytic Leukemia
NCT01064570

Recruiting

AIDA 2000 Guidelines

Conditions: Acute Promyelocytic Leukemia
NCT04562818

Completed

Results From a Mexican Acute Promyelocytic Leukemia.

Conditions: Promyelocytic Leukemia, Acute